<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36763176</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Sequential alterations in diffusion metrics as correlates of disease severity in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>2308</StartPage><EndPage>2313</EndPage><MedlinePgn>2308-2313</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-023-11582-9</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">The neuropathology of amyotrophic lateral sclerosis (ALS) follows a regional distribution pattern in the brain with four stages. Using diffusion tensor imaging (DTI), this pattern can be translated into a tract-based staging scheme to assess cerebral progression in vivo. This study investigates the association between the sequential alteration pattern and disease severity in patients with ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">DTI data of 325 patients with ALS and 130 healthy controls were analyzed in a tract of interest (TOI)-based approach. Patients were categorized according to their ALS-FRS-R scores into groups with declining functionality. The fractional anisotropy (FA) values in the tracts associated with neuropathological stages were group-wise compared with healthy controls.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The FA in the tracts associated with ALS stages showed a decrease which could be related to the disease severity stratification, i.e., at the group level, the lower the ALS-FRS-R of the categorized patient group, the higher was the effect size of the stage-related tract. In the patient group with the highest ALS-FRS-R, Cohen's d showed a medium effect size in the corticospinal tract and small effect sizes in the other stage-related tracts. Overall, the lower the ALS-FRS-R of the categorized patient group the higher was the effect size of the comparison with healthy controls.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The progression of white matter alterations across tracts according to the model of sequential tract involvement is associated with clinical disease severity in patients with ALS, suggesting the use of staging-based DTI as a technical marker for disease progression.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>M&#xfc;ller</LastName><ForeName>Hans-Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Behler</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;nch</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorst</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassubek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7106-9270</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany. jan.kassubek@uni-ulm.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany. jan.kassubek@uni-ulm.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LU 336/15-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>BMBF 01GM1103A</GrantID><Agency>German Network for Motor Neuron Diseases</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019985" MajorTopicYN="N">Benchmarking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016880" MajorTopicYN="N">Anisotropy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011712" MajorTopicYN="N">Pyramidal Tracts</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS-FRS-R</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Clinical score</Keyword><Keyword MajorTopicYN="N">Diffusion tensor imaging</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword></KeywordList><CoiStatement>All authors declare that they have no competing financial or non-financial interests or conflicts of interest that are relevant to the content of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36763176</ArticleId><ArticleId IdType="pmc">PMC10025190</ArticleId><ArticleId IdType="doi">10.1007/s00415-023-11582-9</ArticleId><ArticleId IdType="pii">10.1007/s00415-023-11582-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, et al. Amyotrophic lateral sclerosis&#x2014;a model of corticofugal axonal spread. Nat Rev Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Tredici K, Braak H. Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis. Curr Opin Neurol. 2022;35:660&#x2013;671. doi: 10.1097/WCO.0000000000001098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001098</ArticleId><ArticleId IdType="pubmed">36069419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, M&#xfc;ller H-P, Del Tredici K, et al. Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain. 2014;137:1733&#x2013;1740. doi: 10.1093/brain/awu090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu090</ArticleId><ArticleId IdType="pubmed">24736303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, M&#xfc;ller H-P, Del Tredici K, et al. Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker. J Neurol Neurosurg Psychiatry. 2018;89:374&#x2013;381. doi: 10.1136/jnnp-2017-316365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316365</ArticleId><ArticleId IdType="pmc">PMC5869447</ArticleId><ArticleId IdType="pubmed">29101254</ArticleId></ArticleIdList></Reference><Reference><Citation>Behler A, M&#xfc;ller H-P, Ludolph AC, et al. A multivariate Bayesian classification algorithm for cerebral stage prediction by diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage Clin. 2022;35:103094. doi: 10.1016/j.nicl.2022.103094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103094</ArticleId><ArticleId IdType="pmc">PMC9253469</ArticleId><ArticleId IdType="pubmed">35772192</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Spinelli EG, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses. Expert Rev Neurother. 2018;18:395&#x2013;406. doi: 10.1080/14737175.2018.1463160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2018.1463160</ArticleId><ArticleId IdType="pubmed">29630421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocar TD, M&#xfc;ller H-P, Ludolph AC, Kassubek J. Feature selection from magnetic resonance imaging data in ALS: a systematic review. Ther Adv Chronic Dis. 2021;12:204062232110510. doi: 10.1177/20406223211051002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223211051002</ArticleId><ArticleId IdType="pmc">PMC8521429</ArticleId><ArticleId IdType="pubmed">34729157</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Pagani M, Agosta F, et al. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13:1228&#x2013;1240. doi: 10.1016/S1474-4422(14)70167-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70167-X</ArticleId><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X-Q, Zou T-X, Huang N-X, et al. Brain white matter abnormalities and correlation with severity in amyotrophic lateral sclerosis: an atlas-based diffusion tensor imaging study. J Neurol Sci. 2019;405:116438. doi: 10.1016/j.jns.2019.116438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.116438</ArticleId><ArticleId IdType="pubmed">31484082</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H-P, Turner MR, Grosskreutz J, et al. A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2016;87:570&#x2013;579. doi: 10.1136/jnnp-2015-311952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311952</ArticleId><ArticleId IdType="pubmed">26746186</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Pagani E, Petrolini M, et al. Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol. 2010;31:1457&#x2013;1461. doi: 10.3174/ajnr.A2105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2105</ArticleId><ArticleId IdType="pmc">PMC7966122</ArticleId><ArticleId IdType="pubmed">20395382</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldaranov D, Khomenko A, Kobor I, et al. Longitudinal diffusion tensor imaging-based assessment of tract alterations: an application to amyotrophic lateral sclerosis. Front Hum Neurosci. 2017;11:567. doi: 10.3389/fnhum.2017.00567.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2017.00567</ArticleId><ArticleId IdType="pmc">PMC5723297</ArticleId><ArticleId IdType="pubmed">29259550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Schuff N, Woolley SC, et al. Progression of white matter degeneration in amyotrophic lateral sclerosis: a diffusion tensor imaging study. Amyotroph Lateral Scler. 2011;12:421&#x2013;429. doi: 10.3109/17482968.2011.593036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.593036</ArticleId><ArticleId IdType="pmc">PMC3804304</ArticleId><ArticleId IdType="pubmed">21745124</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Blanco A, Machts J, Acosta-Cabronero J, et al. Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis. Neuroimage Clin. 2016;11:408&#x2013;414. doi: 10.1016/j.nicl.2016.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.03.011</ArticleId><ArticleId IdType="pmc">PMC4827722</ArticleId><ArticleId IdType="pubmed">27104135</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Kliest T, van den Berg LH. Current trends in the clinical trial landscape for amyotrophic lateral sclerosis. Curr Opin Neurol. 2020;33:655&#x2013;661. doi: 10.1097/WCO.0000000000000861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000861</ArticleId><ArticleId IdType="pubmed">32796282</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H-P, Kassubek J. MRI-based mapping of cerebral propagation in amyotrophic lateral sclerosis. Front Neurosci. 2018;12:655. doi: 10.3389/fnins.2018.00655.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00655</ArticleId><ArticleId IdType="pmc">PMC6168650</ArticleId><ArticleId IdType="pubmed">30319338</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H-P, Unrath A, Ludolph AC, Kassubek J. Preservation of diffusion tensor properties during spatial normalization by use of tensor imaging and fibre tracking on a normal brain database. Phys Med Biol. 2007;52:N99&#x2013;N109. doi: 10.1088/0031-9155/52/6/N01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0031-9155/52/6/N01</ArticleId><ArticleId IdType="pubmed">17327646</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H-P, Kassubek J, Gr&#xf6;n G, et al. Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease. BioMed Eng OnLine. 2014;13:128. doi: 10.1186/1475-925X-13-128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-925X-13-128</ArticleId><ArticleId IdType="pmc">PMC4162922</ArticleId><ArticleId IdType="pubmed">25178314</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci. 2002;3:243&#x2013;249. doi: 10.1038/nrn756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn756</ArticleId><ArticleId IdType="pubmed">11994756</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosskopf J, M&#xfc;ller H-P, Dreyhaupt J, et al. Ex post facto assessment of diffusion tensor imaging metrics from different MRI protocols: preparing for multicentre studies in ALS. Amyotroph Lateral Scler Frontotemp Degener. 2015;16:92&#x2013;101. doi: 10.3109/21678421.2014.977297.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.977297</ArticleId><ArticleId IdType="pubmed">25574564</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H-P, Unrath A, Riecker A, et al. Intersubject variability in the analysis of diffusion tensor images at the group level: fractional anisotropy mapping and fiber tracking techniques. Magn Reson Imaging. 2009;27:324&#x2013;334. doi: 10.1016/j.mri.2008.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2008.07.003</ArticleId><ArticleId IdType="pubmed">18701228</ArticleId></ArticleIdList></Reference><Reference><Citation>Behler A, Kassubek J, M&#xfc;ller H-P. Age-related alterations in DTI Metrics in the human brain&#x2014;consequences for age correction. Front Aging Neurosci. 2021;13:682109. doi: 10.3389/fnagi.2021.682109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.682109</ArticleId><ArticleId IdType="pmc">PMC8239142</ArticleId><ArticleId IdType="pubmed">34211389</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawilowsky SS. New effect size rules of thumb. J Mod Appl Stat Methods. 2009;8:597&#x2013;599. doi: 10.22237/jmasm/1257035100.</Citation><ArticleIdList><ArticleId IdType="doi">10.22237/jmasm/1257035100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S, M&#xfc;ller H-P, Ishaque A, et al. A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS. Neurology. 2020;95:e943&#x2013;e952. doi: 10.1212/WNL.0000000000010235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010235</ArticleId><ArticleId IdType="pmc">PMC7668555</ArticleId><ArticleId IdType="pubmed">32646955</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F, Otto M, Silani V. Neurofilament light chain as biomarker for amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci. 2021;15:679199. doi: 10.3389/fnins.2021.679199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.679199</ArticleId><ArticleId IdType="pmc">PMC8255624</ArticleId><ArticleId IdType="pubmed">34234641</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchignoni F, Mora G, Giordano A, et al. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry. 2013;84:1340&#x2013;1345. doi: 10.1136/jnnp-2012-304701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304701</ArticleId><ArticleId IdType="pubmed">23516308</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, de Jongh AD, Nikolakopoulos S, et al. An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials. Amyotroph Lateral Scler Frontotemp Degener. 2021;22:300&#x2013;307. doi: 10.1080/21678421.2021.1879865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1879865</ArticleId><ArticleId IdType="pubmed">33527843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>